Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Gross Profit (2019 - 2025)

Volitionrx (VNRX) has disclosed Gross Profit for 7 consecutive years, with -$535662.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gross Profit rose 7.49% year-over-year to -$535662.0, compared with a TTM value of -$3.1 million through Sep 2025, up 35.14%, and an annual FY2024 reading of -$4.1 million, up 31.92% over the prior year.
  • Gross Profit was -$535662.0 for Q3 2025 at Volitionrx, up from -$798624.0 in the prior quarter.
  • Across five years, Gross Profit topped out at -$401871.0 in Q1 2021 and bottomed at -$2.1 million in Q4 2021.
  • Average Gross Profit over 5 years is -$1.2 million, with a median of -$1.4 million recorded in 2023.
  • The sharpest move saw Gross Profit tumbled 535.21% in 2021, then surged 58.71% in 2024.
  • Year by year, Gross Profit stood at -$2.1 million in 2021, then rose by 26.07% to -$1.6 million in 2022, then decreased by 6.19% to -$1.7 million in 2023, then soared by 35.95% to -$1.1 million in 2024, then surged by 49.47% to -$535662.0 in 2025.
  • Business Quant data shows Gross Profit for VNRX at -$535662.0 in Q3 2025, -$798624.0 in Q2 2025, and -$670914.0 in Q1 2025.